Feed TFX
TF

Teleflex TFX NYSE · Healthcare · United States

$163.51 -1.41% -$2.34

Market cap
$6.49B
Enterprise value
$7.73B
P/E
21.1x
Forward P/E
18.9x
PEG
-
P/S
2.9x
P/FCF
16.7x
EV/EBITDA
24.1x
ROIC
3.2%
Gross margin
58.3%
Net margin
13.6%
Dividend yield
0.83%
Payout ratio
17.6%
Net debt/EBITDA
3.9x
Beta
0.83
Free float
99.6%

About the company

Teleflex Incorporated (TFX) is an American company focused on the development, manufacturing, and distribution of innovative medical devices and products for surgery, anesthesia, cardiovascular care, respiratory therapy, and other fields. With a broad portfolio of products including surgical instruments, catheters, endoscopes, tubes, and ventilators, Teleflex is one of the leading suppliers of medical devices in the market. The company focuses on innovative design, reliability, and user-friendliness of its products to provide effective and safe solutions to physicians and patients. Teleflex also invests in research and development of new technologies and products to continuously improve healthcare and treatment procedures. Teleflex Incorporated (TFX) shares could be suitable for investors looking to invest in companies operating in the medical device sector with an emphasis on innovation, quality, and a wide range of products for various medical specialties.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

CEO

Jason Weidman

Employees

15,500

Headquarters

Wayne

Valuation

Is today's price reasonable?

  • What to watch: The share price is above the Bulios Fair Price.

Growth and estimates

Is it growing, and what comes next?

  • What speaks for it: Analysts expect revenue to grow by 14% this fiscal year.
  • What to watch: Revenue fell by 11% a year over the last 3 years.

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

  • What speaks for it: Out of every 100 USD of revenue, 14 USD is left as net profit.
  • What to watch: It earns only 3.2 USD a year on every 100 USD of invested capital.

Financial health

Can it carry its debt?

  • What to watch: Repaying its net debt would take 3.9 years of operating profit.

Capital and dividends

What does the company do with the money it earns?

  • What speaks for it: It bought back its own shares for $300.0M in the last fiscal year, 4.6% of its market value.

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy